Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 2644876)

Published in Angiology on February 01, 1989

Authors

O Codella1, P Caramaschi, O Olivieri, L Perbellini, A Perbellini, L M Bambara, R Corrocher, G De Sandre

Author Affiliations

1: Università degli Studi di Verona, Italy.

Articles by these authors

Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology (2000) 2.44

Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation") Blood (1995) 2.17

Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med (2000) 1.94

Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood (1998) 1.81

Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) Am J Gastroenterol (1998) 1.74

Hydrocarbon exposure and Parkinson's disease. Neurology (2000) 1.70

alpha-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J Hepatol (1993) 1.58

Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med (2000) 1.53

Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy (2002) 1.51

Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens (1998) 1.51

Chikungunya outbreak--remember the arthropathy. Rheumatology (Oxford) (2006) 1.45

Thrombotic thrombocytopenic purpura developed during ticlopidine therapy. Haematologica (1993) 1.39

Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues. Br J Ind Med (1985) 1.32

NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19

A new case of reactive arthritis after hepatitis B vaccination. Clin Exp Rheumatol (1993) 1.17

Solvent exposure in a shoe upper factory. Int Arch Occup Environ Health (1978) 1.16

High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome. Clin Endocrinol (Oxf) (2013) 1.16

A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol (1995) 1.15

Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br J Ind Med (1981) 1.15

Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol (1988) 1.10

Urinary excretion of n-hexane metabolites in rats and humans. Int Arch Occup Environ Health (1979) 1.10

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1997) 1.09

Cryoglobulinaemia and hepatitis C virus (HCV) infection. Clin Exp Rheumatol (1991) 1.08

Severe impairment of antioxidant system in human hepatoma. Cancer (1986) 1.07

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis (2010) 1.05

Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. Blood (1998) 1.04

Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology (1997) 1.04

Toluene concentrations in the blood and alveolar air of workers during the workshift and the morning after. Br J Ind Med (1986) 1.03

Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood (1994) 1.03

Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport. J Clin Invest (1997) 1.02

Biomonitoring of industrial solvent exposures in workers' alveolar air. Int Arch Occup Environ Health (1980) 1.02

Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord (1995) 1.01

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy (2001) 1.00

Ultrasound differentiation of two types of de Quervain's disease: the role of retinaculum. Ann Rheum Dis (2009) 1.00

Methyl ethyl ketone exposure in industrial workers. Uptake and kinetics. Int Arch Occup Environ Health (1984) 0.99

Reference values for blood benzene in the occupationally unexposed general population. Int Arch Occup Environ Health (1992) 0.99

Alveolar air and blood dichloromethane concentration in shoe sole factory workers. Int Arch Occup Environ Health (1977) 0.99

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy (2004) 0.99

Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine. Toxicol Appl Pharmacol (1980) 0.97

Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study. Clin Rheumatol (2000) 0.97

Benzene in the blood and breath of normal people and occupationally exposed workers. Am J Ind Med (1989) 0.97

Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectrom (1998) 0.97

Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. Arthritis Rheum (2011) 0.96

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96

Clinical, biochemical and molecular findings in a series of families with hereditary hyperferritinaemia-cataract syndrome. Br J Haematol (2001) 0.96

Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women. Int J Obes Relat Metab Disord (1996) 0.95

Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Arch Toxicol (1982) 0.95

[Liver involvement in systemic lupus erythematosus]. Recenti Prog Med (1993) 0.95

Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) (2007) 0.95

Lung uptake and metabolism of cyclohexane in shoe factory workers. Int Arch Occup Environ Health (1980) 0.94

Solvent exposure in a shoe upper factory. II. Methylcyclopentane, 2-methylpentane, and 3-methylpentane concentration in alveolar and in environmental air and in blood. Int Arch Occup Environ Health (1979) 0.94

Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol (1991) 0.94

Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. Arthritis Rheum (2010) 0.94

Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F. Hum Mol Genet (1993) 0.93

Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment. Clin Exp Rheumatol (1993) 0.93

Neutrophil functions and IL-8 in psoriatic arthritis and in cutaneous psoriasis. Inflammation (1998) 0.93

The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med (1996) 0.93

[2,5-hexanedione in biological monitoring of occupational exposure to n-hexane]. Med Lav (1985) 0.93

Experimental neurotoxicity and urinary metabolites of the C5-C7 aliphatic hydrocarbons used as glue solvents in shoe manufacture. Clin Toxicol (1981) 0.92

G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation (2001) 0.92

The Gene-Environment Interactions in Respiratory Diseases (GEIRD) Project. Int Arch Allergy Immunol (2010) 0.92

Decreased band 3 anion transport activity and band 3 clusterization in congenital dyserythropoietic anemia type II. Exp Hematol (1998) 0.92

Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction. Eur J Clin Invest (2004) 0.91

Low selenium status in the elderly influences thyroid hormones. Clin Sci (Lond) (1995) 0.91

Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha? Atherosclerosis (1999) 0.91

Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement. Sarcoidosis Vasc Diffuse Lung Dis (2011) 0.90

Biomonitoring of occupational toluene exposure. Int Arch Occup Environ Health (1982) 0.90

Measurement of the urinary metabolites of N-hexane, cyclohexane and their isomers by gas chromatography. Int Arch Occup Environ Health (1981) 0.90

Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol (1996) 0.90

Three clinical reports of Kikuchi's lymphadenitis combined with systemic lupus erythematosus. Clin Rheumatol (1996) 0.90

Intra-articular injections of hyaluronic acid in the treatment of painful shoulder. Clin Ther (1988) 0.90

The validity of urinary metabolites as indicators of low exposures to toluene. Int Arch Occup Environ Health (1985) 0.90

Anticentromere antibody--clinical associations. A study of 44 patients. Rheumatol Int (1995) 0.89

In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy (2005) 0.89

Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br J Ind Med (1986) 0.88

Composition of pteroylpolyglutamates (conjugated folates) in guinea-pig liver and their formation from folic acid. Clin Sci (1972) 0.88

Membrane cation and anion transport activities in erythrocytes of hereditary spherocytosis: effects of different membrane protein defects. Am J Hematol (1997) 0.88

Elevation of red cell sodium-lithium countertransport in hyperlipidemias. Life Sci (1985) 0.88

Pseudoseptic arthritis in a patient with Behçet's disease. Clin Exp Rheumatol (2006) 0.88